Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery.

IF 3.4 2区 医学 Q2 ONCOLOGY
Annals of Surgical Oncology Pub Date : 2024-12-01 Epub Date: 2024-10-08 DOI:10.1245/s10434-024-16246-0
Eva K Egger, Janina Ullmann, Tobias Hilbert, Damian J Ralser, Laura Tascon Padron, Milka Marinova, Matthias Stope, Alexander Mustea
{"title":"Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery.","authors":"Eva K Egger, Janina Ullmann, Tobias Hilbert, Damian J Ralser, Laura Tascon Padron, Milka Marinova, Matthias Stope, Alexander Mustea","doi":"10.1245/s10434-024-16246-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery.</p><p><strong>Patients and methods: </strong>A total of n = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n = 185 patients) was treated before and cohort B (CB; n = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications.</p><p><strong>Results: </strong>Ultrasevere complications (G4/G5) were exclusively present in CA (p = 0.0025). No difference between cohorts was observed regarding severe complications (G3-G5) (p = 0.062). Median positive fluid excess was lower in CB (p = 0.001). This was independent of tumor load [peritoneal cancer index] (p = 0.001) and FIGO stage (p = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p = 0.001). CB had a shorter length of hospital stay (p = 0.003), less requirement of intensive medical care (p = 0.001) and postoperative ventilation (p = 0.001). CB received higher doses of noradrenalin (p = 0.001). In the combined study cohort, there were more severe complications (G3-G5) in the case of a PFE ≥ 3000 ml (p = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml (p = 0.006).</p><p><strong>Conclusions: </strong>Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.</p>","PeriodicalId":8229,"journal":{"name":"Annals of Surgical Oncology","volume":" ","pages":"8944-8951"},"PeriodicalIF":3.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549190/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1245/s10434-024-16246-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery.

Patients and methods: A total of n = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n = 185 patients) was treated before and cohort B (CB; n = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications.

Results: Ultrasevere complications (G4/G5) were exclusively present in CA (p = 0.0025). No difference between cohorts was observed regarding severe complications (G3-G5) (p = 0.062). Median positive fluid excess was lower in CB (p = 0.001). This was independent of tumor load [peritoneal cancer index] (p = 0.001) and FIGO stage (p = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p = 0.001). CB had a shorter length of hospital stay (p = 0.003), less requirement of intensive medical care (p = 0.001) and postoperative ventilation (p = 0.001). CB received higher doses of noradrenalin (p = 0.001). In the combined study cohort, there were more severe complications (G3-G5) in the case of a PFE ≥ 3000 ml (p = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml (p = 0.006).

Conclusions: Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.

卵巢癌手术的术中体液平衡与围手术期并发症。
背景:体液超负荷和低血容量会导致卵巢癌细胞切除手术患者出现术后并发症。本研究调查了卵巢癌手术中实施脉压变化引导液体管理(PPVGFM)前后的术后并发症和吻合口漏情况:波恩大学医院共对 n = 243 名接受细胞切除手术的卵巢癌患者进行了回顾性评估。A 组(CA;n = 185 名患者)在实施 PPVGFM 之前接受治疗,B 组(CB;n = 58 名患者)在实施 PPVGFM 之后接受治疗。两组患者的术后并发症情况进行了比较:超严重并发症(G4/G5)仅出现在CA组(P = 0.0025)。两组患者在严重并发症(G3-G5)方面无差异(p = 0.062)。CB 中位阳性液体过量率较低(p = 0.001)。这与肿瘤负荷[腹膜癌指数](p = 0.001)和FIGO分期(p = 0.001)无关。CB患者术后首次排便的时间更短(CB:中位数为d2,CA:中位数为d3;p = 0.001)。CB患者的住院时间更短(p = 0.003),对重症监护的需求更少(p = 0.001),术后通气时间更短(p = 0.001)。CB 接受的去甲肾上腺素剂量更高(p = 0.001)。在合并研究队列中,PFE ≥ 3000 毫升的患者出现更多严重并发症(G3-G5)(p = 0.034),PFE ≥ 4000 毫升的患者出现更多吻合口漏(p = 0.006):结论:根据 PPVGFM 在卵巢癌手术中减少术中液体是安全的,并能显著减少超严重术后并发症。PFE≥3000毫升和≥4000毫升分别被确定为严重并发症和吻合口漏的临界值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
10.80%
发文量
1698
审稿时长
2.8 months
期刊介绍: The Annals of Surgical Oncology is the official journal of The Society of Surgical Oncology and is published for the Society by Springer. The Annals publishes original and educational manuscripts about oncology for surgeons from all specialities in academic and community settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信